celecoxib has been researched along with Colitis-Associated Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mao, L | 1 |
| Yang, J | 1 |
| Yue, J | 1 |
| Chen, Y | 1 |
| Zhou, H | 1 |
| Fan, D | 1 |
| Zhang, Q | 1 |
| Buraschi, S | 1 |
| Iozzo, RV | 1 |
| Bi, X | 1 |
1 other study available for celecoxib and Colitis-Associated Cancer
| Article | Year |
|---|---|
Decorin deficiency promotes epithelial-mesenchymal transition and colon cancer metastasis.
Topics: Animals; Azoxymethane; beta Catenin; Cadherins; Cancer-Associated Fibroblasts; Celecoxib; Colitis-As | 2021 |